Physician

Shripaad Y Shukla, M.D.

According to 2025 Medicare claims, Shripaad Shukla, M.D. (NPI: 1467727735) practices ophthalmology in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Allegheny, PA. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS INC. (NPI: 1063444123; TIN: 251492985) and primary practice location at 16601-4812.

Shukla's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 641 traditional Medicare patients, billed 31,805 HCPCS/CPT codes, and received $1,921,860 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 363 prescription claims across 144 beneficiaries totaling $8,557 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,953 to $1,921,860. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $35,404 to $8,557. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$961K$1.9M2016 Medicare payment: $2,953 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,978 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $151,020 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $600,682 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $709,978 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,003,516 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,203,157 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,406,043 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,921,860 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20162846$2,953
20174161$4,978
2018236800$151,020
20195433,590$600,682
20205303,819$709,978
20215664,810$1,003,516
20225225,729$1,203,157
202354014,220$1,406,043
202464131,805$1,921,860

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$18K$35K2015 Drug cost: $35,404 (USD; Tot_Drug_Cst)2016 Drug cost: $23,004 (USD; Tot_Drug_Cst)2017 Drug cost: $1,167 (USD; Tot_Drug_Cst)2018 Drug cost: $2,824 (USD; Tot_Drug_Cst)2019 Drug cost: $12,930 (USD; Tot_Drug_Cst)2020 Drug cost: $12,887 (USD; Tot_Drug_Cst)2021 Drug cost: $12,496 (USD; Tot_Drug_Cst)2022 Drug cost: $14,318 (USD; Tot_Drug_Cst)2023 Drug cost: $9,974 (USD; Tot_Drug_Cst)2024 Drug cost: $8,557 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015126332$35,404
201677281$23,004
20171537$1,167
20184171$2,824
2019106386$12,930
2020123385$12,887
2021122340$12,496
2022135415$14,318
2023135368$9,974
2024144363$8,557

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1611,256$658
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more126126$124
67028Injection of drug into eye3311,160$94
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more456800$67
92134Imaging of retina5751,120$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate552,262$2,203
Ketorolac TromethamineKetorolac Tromethamine1103,294$1,789
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat453,860$608
LatanoprostLatanoprost483,229$506
Dorzolamide HclDorzolamide Hcl13650$392

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Shripaad Y. Shukla, M.D.?

Tedicare shows public-source Medicare data for Shripaad Y. Shukla, M.D. (NPI 1467727735), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shripaad Y. Shukla, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Shripaad Y. Shukla, M.D.?

Shripaad Y. Shukla, M.D. is linked to RETINA VITREOUS CONSULTANTS INC. (billing NPI 1063444123) in the available physician profile data.

Does Shripaad Y. Shukla, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.